Due to the impact of COVID-19 and associated travel and physical distancing restrictions the 7th Thomas Ashworth Symposium has been delayed until 21-22nd October 2021, at which time we plan to hold it as an in-person Symposium at the Aerial UTS Function Centre, Sydney
7th Thomas Ashworth Symposium (TAS2021)
Date: 21-22 October 2021
Registration opens: 19th July 2021
Final registration closes: 18th October 2021
Showcasing the best of international and national liquid biopsy research
The Thomas Ashworth CTC & Liquid Biopsy Symposium is devoted to advancing the clinical application of liquid biopsy to enhance precision oncology and improve patient outcome as well as provide critical insights into the metastatic process, minimal residual disease and cancer biology.
An exciting line up of international leaders in the field, supported by national speakers from across Australia will be showcasing their liquid biopsy research.
Confirmed 2021 Keynote Speakers
• Professor Razelle Kurzrock (MD, PhD). University of California, San Diego, USA • Professor Maarten IJzerman (PhD). University of Melbourne, Australia
• Professor Sarah-Jane Dawson (MBBS, PhD). Peter Mac, Australia
• Dr Jenny Lee (MBBS, PhD). Macquarie University, Chris O'Brien Lifehouse, Australia
• Dr Ira Deveson (PhD). Kinghorn Centre for Clinical Genomics, Australia
Topics to be explored include circulating tumour cells, ctDNA, exosomes, methlated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring, recurrence and drug resistance monitoring. In addition, the opportunities and challenges involving the health economics of liquid biopsy and the regulatory landscape will be presented.
Who should attend?
Clinical trainees, PhD and other students
Pharmaceutical and diagnostic sector
For more information please email firstname.lastname@example.org